Author:
Acharya Sourya,Kumar Sunil,Talwar Dhruv,Raisinghani Nitin,Madaan Sparsh,Hulkoti Vidyashree,Akhilesh Annadatha,Khanna Shivam,Shah Divit,Nimkar Shubham
Publisher
Jaypee Brothers Medical Publishing
Subject
Critical Care and Intensive Care Medicine
Reference10 articles.
1. 1. Zhang J, Hao Y, Ou W, Ming F, Liang G, Qian Y, et al. Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study. J Transl Med 2020;18(1):406. DOI: 10.1186/s12967-020-02571-x.
2. 2. Grifoni E, Valoriani A, Cei F, Lamanna R, Gelli AMG, Ciambotti B, et al. Interleukin-6 as prognosticator in patients with COVID-19. J Infect 2020;81(3):452–482. DOI: 10.1016/j.jinf.2020.06.008.
3. 3. Coomes EA, Haghbayan H. Interleukin-6 in Covid-19: a systematic review and meta-analysis. Rev Med Virol 2020;30(6):e2141. DOI: 10.1002/rmv.2141.
4. 4. Montesarchio V, Parrella R, Iommelli C, Bianco A, Manzillo E, Fraganza F, et al. Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy. J Immunother Cancer 2020;8(2):e001089. DOI: 10.1136/jitc-2020-001089.
5. 5. Conrozier T, Lohse A, Balblanc JC, Dussert P, Royer PY, Bossert M, et al. Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease-2019 (COVID-19): results of a multidisciplinary collaboration. Clin Exp Rheumatol 2020;38(4): 742–747. PMID: 32573419.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献